A-wave

About A-wave

A-wave Inc. is a medical technology company established in May 2023, originating as a venture from Osaka University. The firm was founded by Hiroaki Masuda, who serves as the President and CEO. Masuda's background as a Specially Appointed Assistant Professor at Osaka University's Graduate School of Medicine and his experience in the Stanford Biodesign program directly inform the company's direction. His research on chronic heart failure is the foundational basis for A-wave's core technology.

The company is focused on addressing the high re-admission rates for chronic heart failure patients, a significant issue in Japan's aging society where nearly 40% of such patients are readmitted. To tackle this, A-wave is developing a comprehensive remote monitoring system for at-home patients. This system aims to detect early signs of worsening heart failure, enabling timely medical intervention and preventing rehospitalization. The target clients are primarily medical institutions and patients dealing with chronic heart failure.

A-wave's flagship product is a non-invasive, watch-type wearable device complemented by a dedicated smartphone application and an AI-driven cloud platform. The device is engineered to continuously monitor key physiological indicators that signal the exacerbation of heart failure, such as heart murmurs, decreased physical activity, and peripheral coldness. By analyzing this data, the system allows for the early detection of symptoms, effectively providing patients with daily, specialist-level virtual examinations from their own homes. The company has secured significant funding to accelerate the development of this diagnostic technology, conduct further clinical trials, and prepare for market entry.